Related Experiment Video

Updated: Jun 20, 2026

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes
11:52

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes

Published on: January 27, 2023

Growth/differentiation factor-15 inhibits differentiation into osteoclasts--a novel factor involved in control of

Petr Vanhara1, Eva Lincová, Alois Kozubík

  • 1Department of Experimental Biology, Faculty of Science, Masaryk University, Kotlárská 2, CZ 611 37 Brno, Czech Republic.

Differentiation; Research in Biological Diversity
|August 22, 2009
PubMed

Insights

Growth/differentiation factor-15 (GDF-15) inhibits the formation of osteoclasts, which are cells responsible for bone breakdown. This finding suggests GDF-15 may play a role in treating prostate cancer bone metastases.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Prostate cancer bone metastases significantly impact bone remodeling, causing osteolytic and osteocondensing lesions.
  • The precise molecular mechanisms governing cancer cell interactions within the bone microenvironment remain incompletely understood.

Purpose of the Study:

  • To investigate the role of Growth/differentiation factor-15 (GDF-15) in the context of prostate cancer and its potential effects on bone microenvironment modulation.
  • To elucidate the molecular mechanisms by which GDF-15 influences osteoclast differentiation and activity.

Main Methods:

  • Utilized prostate adenocarcinoma LNCaP cells treated with 1,25(OH)(2)-vitamin D(3) to generate GDF-15.
  • Assessed the impact of GDF-15 on osteoclast differentiation from RAW264.7 macrophages and bone-marrow precursors stimulated by M-CSF/RANKL.
  • Analyzed the effects of GDF-15 on key signaling pathways including NFkappaB, SMAD, and p38, as well as the expression of osteoclast-specific enzymes like carbonic anhydrase II and cathepsin K.

Main Results:

  • GDF-15 significantly suppressed the formation of mature osteoclasts in a dose-dependent manner.
  • GDF-15 inhibited the expression of c-Fos and NFkappaB activity through delayed IkappaB degradation.
  • GDF-15 reduced the expression of carbonic anhydrase II and cathepsin K, and altered SMAD and p38 signaling pathways.

Conclusions:

  • GDF-15 plays a novel role in modulating osteoclast differentiation, potentially by inhibiting bone resorption.
  • The findings suggest GDF-15 could be a therapeutic target for managing bone metastases in prostate cancer.

More Related Videos

Differentiation and Characterization of Osteoclasts from Human Induced Pluripotent Stem Cells10:52

Differentiation and Characterization of Osteoclasts from Human Induced Pluripotent Stem Cells

Published on: March 22, 2024

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...